Cambridge's Dimension slashes headcount after lead drug flops By: Boston Business Journal via Business Journals June 28, 2017 at 10:12 AM EDT The reorganization will see the gene therapy biotech cut around 25 percent of its workforce by the end of the year. Read More >>